Conflict of interest
The authors declare no conflicts of interest concerning this article.
.
[1] Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA: a cancer journal for clinicians. 2001;51:15-36.
[2] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: a cancer journal for clinicians. 2013;63:11-30.
[3] Chen P-L, Zhao T, Feng R, Chai J, Tong G-X, Wang D-B. Patterns and Trends with Cancer Incidence and Mortality Rates Reported by the China National Cancer Registry. Asian Pacific Journal of Cancer Prevention. 2014;15:6327-32.
[4] Kadioglu O, Kermani NS, Kelter G, Schumacher U, Fiebig HH, Greten HJ, et al. Pharmacogenomics of cantharidin in tumor cells. Biochemical pharmacology. 2014;87:399-409.
[5] Liao HF, Su SL, Chen YJ, Chou CH, Kuo CD. Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2007;45:1678-87.
[6] Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. The EMBO journal. 2008;27:433-46.
[7] Kubli DA, Gustafsson AB. Mitochondria and mitophagy: the yin and yang of cell death control. Circulation research. 2012;111:1208-21.
[8] Hu ZY, Zhu XF, Zhong ZD, Sun J, Wang J, Yang D, et al. ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts. International journal of cancer Journal international du cancer. 2008;123:2418-29.
[9] Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Human molecular genetics. 2011;20:1726-37.
[10] Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
[11] Fan YZ, Zhao ZM, Fu JY, Chen CQ, Sun W. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo. Hepatobiliary & pancreatic diseases international : HBPD INT. 2010;9:414-22.
[12] Chen YN, Chen JC, Yin SC, Wang GS, Tsauer W, Hsu SF, et al. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. International journal of cancer Journal international du cancer. 2002;100:158-65.
[13] Ye L, Yuan G, Xu F, Sun Y, Chen Z, Chen M, et al. The small-molecule compound BM-1197 inhibits the antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death in human colorectal cancer cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36:3447-55.
[14] Vera Y, Erkkila K, Wang C, Nunez C, Kyttanen S, Lue Y, et al. Involvement of p38 mitogen-activated protein kinase and inducible nitric oxide synthase in apoptotic signaling of murine and human male germ cells after hormone deprivation. Molecular endocrinology. 2006;20:1597-609.
[15] Edlich F, Banerjee S, Suzuki M, Cleland MM, Arnoult D, Wang C, et al. Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol. Cell. 2011;145:104-16.
[16] Liu X, Kim CN, Pohl J, Wang X. Purification and characterization of an interleukin-1beta-converting enzyme family protease that activates cysteine protease P32 (CPP32). The Journal of biological chemistry. 1996;271:13371-6.
[17] Rabinowitz JD, White E. Autophagy and metabolism. Science. 2010;330:1344-8.
[18] Tormo D, Checinska A, Alonso-Curbelo D, Perez-Guijarro E, Canon E, Riveiro-Falkenbach E, et al. Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer cell. 2009;16:103-14.
[19] Melser S, Lavie J, Benard G. Mitochondrial degradation and energy metabolism. Biochimica et biophysica acta. 2015;1853:2812-21.
[20] Beck JT, Ismail A, Tolomeo C. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma. Cancer treatment reviews. 2014;40:980-9.
[21] Guo Y, Li Y, Shan Q, He G, Lin J, Gong Y. Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia. The international journal of biochemistry & cell biology. 2015;65:1-11.
[22] Kumar D, Shankar S, Srivastava RK. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms. Molecular cancer. 2013;12:171.
[23] Avalos Y, Canales J, Bravo-Sagua R, Criollo A, Lavandero S, Quest AF. Tumor suppression and promotion by autophagy. BioMed research international. 2014;2014:603980.
[24] Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. The Journal of biological chemistry. 2005;280:32081-9.
[25] Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia. 2012;55:2565-82.
[26] Shen B, He PJ, Shao CL. Norcantharidin induced DU145 cell apoptosis through ROS-mediated mitochondrial dysfunction and energy depletion. PloS one. 2013;8:e84610.